« Previous
Next »
Subjects
- Biomarkers1
- Clinical Trials as Topic1
- Drug Approval1
- Drug Development1
- Drugs, Investigational1
- Endpoint Determination1
- Hematologic Neoplasms -- drug therapy1
- Humans1
- Investigational New Drug Application1
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy1
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy1
- Leukemia, Myeloid, Acute -- drug therapy1
- Leukemia, Promyelocytic, Acute -- drug therapy[remove]1
- Multiple Myeloma -- drug therapy1
- Neoplasm, Residual1
- Patient Selection1
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy1
- Prognosis1
- United States1
- United States. Department of Health and Human Services.1